- Investor's Business Daily•19 days ago
Shares of specialty drugmaker Depomed (DEPO) were selling off Thursday after UBS downgraded it, citing slowing sales of key drugs. Analyst Ami Fadia rated the stock neutral, down from buy, while maintaining ...
- Capital Cube•28 days ago
Click here to see latest analysis*Disclaimer : This is as of previous day’s closing price.Technical IndicatorsBelow is a quick look at 5 technical indicators for Depomed, Inc.. More studies are available on the Technical Chart.IndicatorSignalClosing Price above/below 50 Day Moving AverageBearishClosing Price above/below 200 Day Moving AverageBullish50 Day Moving Average above/below 200 Day Moving AverageBullishRSI […] (Read more...) The post Depomed, Inc. breached its 50 day moving average in a Bearish Manner : DEPO-US : June 28, 2016 appeared first on CapitalCube.
|Bid||18.89 x 300|
|Ask||18.89 x 100|
|52wk Range||12.25 - 33.17|
|Day's Range||18.81 - 19.28|
|Avg Vol (3m)||1,395,103|
As of 1:47 PM EDT. NasdaqGS Real Time Price. Market open.